Jazz Pharmaceuticals
JAZZ
#1410
Rank
ยฃ11.28 B
Marketcap
ยฃ175.84
Share price
-2.62%
Change (1 day)
30.44%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): ยฃ2.71

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ2.77. In 2025 the company made an earnings per share (EPS) of -ยฃ4.42 a decrease over its 2024 EPS that were of ยฃ6.96.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ2.71-161.22%
2025-ยฃ4.42-163.56%
2024ยฃ6.9639.08%
2023ยฃ5.00-285.03%
2022-ยฃ2.70-34.2%
2021-ยฃ4.11-224.83%
2020ยฃ3.29-53.25%
2019ยฃ7.0423.59%
2018ยฃ5.70-8.24%
2017ยฃ6.2123.74%
2016ยฃ5.0222.12%
2015ยฃ4.11478.49%
2014ยฃ0.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
ยฃ4.01 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
ยฃ6.33 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-ยฃ0.82-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
ยฃ0.34-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel